Email not displaying properly? View email in your browser
Vertical-Talk Pharma   >  New organic micro-pollutants
>  Parkinson’s Disease
>  TumorInduced Osteomalacia
  Jan 2021   e-Newsletter Advertise | Editorial Calendar  
Eppendorf Discover the Flow
Latest e-book
News
Agenus Enters into Clinical Collaboration...
BioNTech and Fosun Pharma Receive...
Press Releases
Shimadzu & Changi General Hospital jointly...
Samsung Biologics, National OncoVenture...
Events
03 - 04 Feb 2021
Biotechnology 2021
16 - 18 Feb 2021
CAR-TCR Europe 2021
Articles
>  Endocrine Disrupting Compounds (EDCs)
     Problems and Remedy by Nanotechnology-Based Approaches
Sintu Kumar Samanta, Assistant Professor, IIIT Allahabad
Pavan Kumar Gautam, Post-Doctoral Fellow, Applied Sciences, IIIT Allahabad
Endocrine Disrupting Compounds (EDCs) have emerged as a new class of organic micro-pollutants imposing detrimental effects on living beings. Minimisation of these pollutants from water bodies is essential for aquatic ecology as well as humans. In this context, nanomaterials are gaining immense importance for scavenging and degradation of these EDCs...
Techno Trends
> SUNOVION Launches KYNMOBI for the Treatment of Parkinsons...
> Crysvita - A Breakthrough Therapy Developed For Treatment of...
> New Xolair Treats Severe Rhinosinusitis with Nasal Polyps
Projects
> Luina Bio Expands with New Manufacturing Facilities
> Romark Constructs New Manufacturing Facility in Manati
> Metrics Expands Manufacturing Facility in North Carolina
Research Insights
> Early exposure to broadly neutralizing antibodies may a dynamical...
> Cell signaling model for arterial mechanobiology
> Occurrence and transmission potential of asymptomatic and...
  Subscribe  |  e-Book Archives  | Advisory Board  
Follow Us Facebook Twitter linkedin
www.pharmafocusasia.com - Owned by Ochre Media Pvt. Ltd.